PTPRC and cancer: Notably, protein targets associated with B cells (CD20), macrophages (CD68), Treg cells (PD-1, FOXP3), and NK cells (CD56) exhibited significant differential expression within CD45+ segments located in regions of immune-rich cancer cell islet compared to the adjacent stromal leukocytes.